retatrutide approval status 2025 retatrutide fda approval Commercial Availability Timeline: Key Milestones and Costs ⚠️ BEWARE OF RETATRUTIDE SOLD

Judging a dose's effectiveness before steady state leads to premature escalation

At the weight-management dose of 2.4 mg, the largest pooled analysis of four placebo-controlled trials in 3,087 adults without diabetes found an average weight loss of 12.1% (about 12.3 kg) at 68 weeks compared to placebo, and 33% of participants lost at least 20% of their starting weight

As a physician, I often prescribe GLP-1 agonists to help manage weight and blood sugar levels in patients with obesity and diabetes

But before you dive in, lets address the big question: how much weight can you really lose in just one month using GLPs like Ozempic, Wegovy, or Mounjaro